Evotec SEÂ (EVO)Â
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
EVO Insider Trading Activity
EVO Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Insider Activity of Evotec SE
Over the last 12 months, insiders at Evotec SE have bought $0 and sold $0 worth of Evotec SE stock.
On average, over the past 5 years, insiders at Evotec SE have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 392 shares for transaction amount of $5,023 was made by BANK OF AMERICA CORP /DE/ (10 percent owner) on 2011‑10‑18.
List of Insider Buy and Sell Transactions, Evotec SE
| 2011-10-18 | Sale | BANK OF AMERICA CORP /DE/ | 10 percent owner | 392 0.0003% | $12.75 | $4,999 | +2.53% | |
| 2011-10-18 | BANK OF AMERICA CORP /DE/ | 10 percent owner | 392 0.0003% | $12.81 | $5,023 | +2.53% |
EVO Institutional Investors: Active Positions
| Increased Positions | 15 | +50% | 2M | +18.8% |
| Decreased Positions | 13 | -43.33% | 607,723 | -7.61% |
| New Positions | 8 | New | 74,884 | New |
| Sold Out Positions | 6 | Sold Out | 267,730 | Sold Out |
| Total Postitions | 32 | +6.67% | 9M | +11.18% |
EVO Ownership Change vs Market
Institutional Investor Ownership
| Mubadala Investment Co Pjsc | $16,138.00 | 1.29% | 4.6M | 0 | 0% | 2024-12-31 |
| Wellington Management Group Llp | $8,073.00 | 0.65% | 2.3M | -334,529 | -12.7% | 2024-12-31 |
| Blackrock, Inc. | $5,069.00 | 0.41% | 1.44M | +1M | +2,722.82% | 2024-12-31 |
| Dcf Advisers, Llc | $807.00 | 0.07% | 229,871 | +12,816 | +5.9% | 2024-12-31 |
| Morgan Stanley | $442.00 | 0.04% | 125,921 | +3,467 | +2.83% | 2024-12-31 |
| Goldman Sachs Group Inc | $215.00 | 0.02% | 61,118 | +3,977 | +6.96% | 2024-12-31 |
| Lighthouse Investment Partners, Llc | $140.00 | 0.01% | 39,803 | +39,803 | New | 2024-12-31 |
| Vanguard Personalized Indexing Management, Llc | $45.00 | <0.01% | 12,836 | +12,836 | New | 2024-12-31 |
| Bank Of America Corp /De/ | $45.00 | <0.01% | 12,828 | +9,289 | +262.48% | 2024-12-31 |
| Css Llc/Il | $42.00 | <0.01% | 12,100 | +12,100 | New | 2024-12-31 |